bluebird bio (BLUE) call put ratio 6.8 calls to 1 put into confirms FDA approval of Zynteglo

bluebird bio (NASDAQ: BLUE) 30-day option implied volatility is at 192; compared to its 52-week range of 61 to 184 into confirms FDA approval of Zynteglo. Call put ratio 6.8 calls to 1 put.

You May Also Be Interested In

• Micron Technology (MU) call put ratio 1.2 calls to 1 put into quarter results
• SentinelOne, Inc. (S) call put ratio 3.9 calls to 1 put with a focus on July 15 and 16 calls as share price up 3.4%
• Varonis Systems (VRNS) call put ratio 4.4 calls to 1 put with a focus on July 35, 40 and 45 calls as share price up 6.4%